Russian plant inspections will cost foreign drugmakers $38,000

Up to 3 million roubles (~$38,000) will be paid by foreign pharmaceutical companies, supplying their drugs to the Russian market, for the inspections of their plants by Russian inspectors, according to recent calculations of the Russian Ministry of Health.

It is planned that inspections will be carried out in accordance with the Russian legislation and will be conducted by the experts of the Russian State Institute for Drugs and Good Practices (RSIDGP), reports The Pharma Letter’s local correspondent.

According to recent statements of the Russian Ministry of Health, starting from January 1, 2016, foreign pharmaceutical companies cannot register their new drugs in Russia unless their quality standards conform to the Russian quality standards, based on Good Manufacturing Practice (GMP) requirements.